Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-AGE study of rFSH versus rFSH + rLH in IVF/ICSI
NL-OMON21944Recruiting
- Sponsor
- Merck & Co.
- Start
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in female infertility and Diminished Ovarian Reserve (DOR) comparing rFSH alone with rFSH + rLH (2:1 ratio) (2 arms). Primary endpoint: Percentage of top-quality embryos. Started Sep 2008; status: recruiting.
02
Drugs
follitropin alfalutropin alfa
03
Conditions
female infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NL-OMON21944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21944.